Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching ...
Accenture CEO Julie Sweet diagnosed with early-stage breast cancer, treatment likely to last 12-16 weeks
Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.
Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness
Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...
Meet CEO of one of world's biggest IT firms, who will undergo treatment for breast cancer
Julie Sweet, Chief Executive Officer of Accenture has recently been diagnosed with early-stage breast cancer and will undergo the treatment for about 12-16 weeks.